Robert Hollingsworth

Person

Gaithersburg, MD, US

People

Patents Grantslast 30 patents

Information Patent Grant
Binding molecules specific for ASCT2 and uses thereof
- Patent number 11,608,375
- Issue date Mar 21, 2023
- MedImmune, LLC
- Nabendu Pore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Binding molecules specific for CD73 and uses thereof
- Patent number 11,525,012
- Issue date Dec 13, 2022
- MedImmune Limited
- Carl Hay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Binding molecules specific for ASCT2 and uses thereof
- Patent number 10,829,554
- Issue date Nov 10, 2020
- MedImmune, LLC
- Nabendu Pore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binding molecules specific for CD73 and uses thereof
- Patent number 10,556,968
- Issue date Feb 11, 2020
- MedImmune Limited
- Carl Hay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Binding molecules specific for CD73 and uses thereof
- Patent number 10,287,362
- Issue date May 14, 2019
- MedImmune Limited
- Carl Hay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Binding molecules specific for CD73 and uses thereof
- Patent number 9,938,356
- Issue date Apr 10, 2018
- MedImmune Limited
- Carl Hay
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF
- Publication number 20230340152
- Publication date Oct 26, 2023
- MEDIMMUNE LIMITED
- Carl HAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-DRUG CONJUGATES WITH IMMUNE-MEDIATED THERAPY AGENTS
- Publication number 20220211864
- Publication date Jul 7, 2022
- MEDIMMUNE LIMITED
- ROBERT E. HOLLINGSWORTH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES SPECIFIC FOR ASCT2 AND USES THEREOF
- Publication number 20210024629
- Publication date Jan 28, 2021
- Medimmune, LLC
- Nabendu Pore
- G01 - MEASURING TESTING
Information Patent Application
BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF
- Publication number 20200079877
- Publication date Mar 12, 2020
- MEDIMMUNE LIMITED
- Carl HAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-DRUG CONJUGATES WITH IMMUNE-MEDIATED THERAPY AGENTS
- Publication number 20200023072
- Publication date Jan 23, 2020
- MEDIMMUNE LIMITED
- ROBERT E. HOLLINGSWORTH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Binding Molecules Specific For ASCT2 And Uses Thereof
- Publication number 20190367605
- Publication date Dec 5, 2019
- Medimmune, LLC
- Nabendu Pore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF
- Publication number 20190292274
- Publication date Sep 26, 2019
- MedImmune Limited
- Carl HAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC COMBINATIONS FOR TREATING NEOPLASIA
- Publication number 20190076452
- Publication date Mar 14, 2019
- MEDIMMUNE LIMITED
- Jonathan RIOS-DORIA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES SPECIFIC FOR ASCT2 AND USES THEREOF
- Publication number 20180273617
- Publication date Sep 27, 2018
- MedImmune, LLC
- Nabendu Pore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF
- Publication number 20180194858
- Publication date Jul 12, 2018
- MEDIMMUNE LIMITED
- Carl HAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF
- Publication number 20160194407
- Publication date Jul 7, 2016
- Carl HAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Robert Hollingsworth

Person

Patents Grantslast 30 patents

Binding molecules specific for ASCT2 and uses thereof

Binding molecules specific for CD73 and uses thereof

Binding molecules specific for ASCT2 and uses thereof

Binding molecules specific for CD73 and uses thereof

Binding molecules specific for CD73 and uses thereof

Binding molecules specific for CD73 and uses thereof

Patents Applicationslast 30 patents

BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF

ANTIBODY-DRUG CONJUGATES WITH IMMUNE-MEDIATED THERAPY AGENTS

BINDING MOLECULES SPECIFIC FOR ASCT2 AND USES THEREOF

BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF

ANTIBODY-DRUG CONJUGATES WITH IMMUNE-MEDIATED THERAPY AGENTS

Binding Molecules Specific For ASCT2 And Uses Thereof

BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF

THERAPEUTIC COMBINATIONS FOR TREATING NEOPLASIA

BINDING MOLECULES SPECIFIC FOR ASCT2 AND USES THEREOF

BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF

BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF